Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 55 out of 100. Digital health tools

Topic: Amyloid, tau and blood-test diagnosis

Portable, low-field magnetic resonance imaging (LF-MRI) of the brain may facilitate point-of-care assessment of patients with Alzheimer's disease (AD) in settings where conventional MRI cannot. However, image quality is limited by a lower signal-to-noise ratio. Here, we optimize LF-MRI acquisition and develop a freely available machine learning pipeline to quantify brain morphometry and white matter hyperintensities (WMH). We validate the pipeline and apply it to outpatients presenting with mild cognitive impairment or dementia due to AD. We find hippocampal volumes from ≤ 3 mm isotropic LF-MRI scans have agreement with conventional MRI and are more accurate than anisotropic counterparts. We also show WMH volume has agreement between manual segmentation and the automated pipeline. The increased availability and reduced cost of LF-MRI, in combination with our machine learning pipeline, has the potential to increase access to neuroimaging for dementia.

Key findings

Why it matters

This study optimized portable, low-field MRI acquisition and developed a machine learning pipeline to quantify brain morphometry and white matter hyperintensities in patients with mild cognitive impairment or dementia due to Alzheimer's disease. Hippocampal volumes from these scans agreed with conventional MRI, and the authors suggest this could increase access to neuroimaging for dementia.

Study details

How this study scored 55/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 4 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 4 of 7; Citations per year 3 of 5; Impact for its field and year 4 of 6; Cited by studies here 2 of 6; Still being cited 2 of 4; Senior author's track record 3 of 4; Institution's track record 3 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 55 of 100.55 of 100 points earned45 not earned

Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Nature communications)
Journal's citation record 4 / 4 Nature Communications: journal h-index 747 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2024 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 43 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 10.8 citations a year over 4 year(s) since 2024
Impact for its field and year 4 / 6 Cited 11.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 3 other studies in this library
Still being cited 2 / 4 Cited 43 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author William Taylor Kimberly: h-index 59 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 5 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 39622805)
Free to read 2 / 2 Free to read
Total 55 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Sorby-Adams, A. J., Guo, J., Laso, P., Kirsch, J. E., Zabinska, J., Garcia Guarniz, A. L., et al. (2024). Portable, low-field magnetic resonance imaging for evaluation of Alzheimer's disease. Nature communications. https://doi.org/10.1038/s41467-024-54972-x

Vancouver

Sorby-Adams AJ, Guo J, Laso P, Kirsch JE, Zabinska J, Garcia Guarniz AL, et al. Portable, low-field magnetic resonance imaging for evaluation of Alzheimer's disease. Nature communications. 2024. doi:10.1038/s41467-024-54972-x. PMID: 39622805.

BibTeX

@article{sorbyadams2024-39622805,
  author  = {Sorby-Adams, A. J. and Guo, J. and Laso, P. and Kirsch, J. E. and Zabinska, J. and Garcia Guarniz, A. L. and Schaefer, P. W. and Payabvash, S. and others},
  title   = {{Portable, low-field magnetic resonance imaging for evaluation of Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2024},
  doi     = {10.1038/s41467-024-54972-x},
  pmid    = {39622805},
  url     = {https://doi.org/10.1038/s41467-024-54972-x}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 23.

Later studies that cite this one

3 studies in the alzhub library list this one in their references.

Related studies in Digital health tools

Similar studies

More on Digital health tools

See all studies in Digital health tools →